Abstract
We describe the incidence of cancer in The Gambia over a 10-year period using data collected through the Gambian National Cancer Registry. Major problems involved with cancer registration in a developing country, specifically in Africa are discussed. The data accumulated show a low overall rate of cancer incidence compared to more developed parts of the world. The overall age standardized incidence rates (ASR) were 61.0 and 55.7 per 100 000 for males and females, respectively. In males, liver cancer was most frequent, comprising 58% of cases (ASR 35.7) followed by non-Hodgkin lymphoma, 5.4% (ASR 2.4), lung 4.0%, (ASR 2.8) and prostate 3.3% (ASR 2.5) cancers. The most frequent cancers in females were cervix uteri 34.0% (ASR 18.9), liver 19.4% (ASR 11.2), breast 9.2% (ASR 5.5) and ovary 3.2% (ASR 1.6). The data indicate that cancers of the liver and cervix are the most prevalent cancers, and are likely to be due to infectious agents. It is hoped that immunization of children under 1 year against hepatitis B will drastically reduce the incidence of liver cancer in The Gambia. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Allen SJ, Wild CP, Wheeler JG, Riley EM, Montesano R, Bennet S, Whittle HC, Hall AJ and Greenwood BM (1992) Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 86: 426–430
Ariyoshi K, Schim Van Der Loeff M, Cook P, Whitby D, Corrah T and Jaffar S (1998) Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpes virus 8. J Hum Virol 1: 193–199
Bah E, Hall AJ and Inskip HM (1990) The first 2 years of the Gambian National Cancer Registry. Br J Cancer 62: 647–650
Brinton LA, Reeves WC, Brenes MM, Herrero R, De Britton RC, Gaitan E, Tenorio F, Garcia M and Rawls WE (1989) Parity as a risk factor for cervical cancer. Am J Epidemiol 130: 486–496
Chokunonga E, Levy LM, Bassett MT, Mauchaza BG, Thomas DB and Parkin DM (2000) Cancer Incidence in the African Population of Harare, Zimbabwe: Second Results from the Cancer Registry 1993–1995. Int J Cancer 85: 54–59
Cooke A (1998) CANREG-3 Manual. International Agency for Research on Cancer: Lyon, France
De Sanjose S, Muñoz N, Bosch FX, Reimann K, Pedersen NS, Orfila J, Ascunce N, Gonzalez LC, Tafur L and Gili M (1994) Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 56: 358–363
Doll R, Payne P and Waterhouse J (1966). Cancer Incidence in Five Continents, Vol, Springer-Verlag: Berlin
Echimane AK, Ahnoux AA, Adoubi I, Hien S, M'bra K, D'horpock A, Diomande M, Anongba D, Mensah-Adoh I and Parkin DM (2000) Cancer incidence in Abidjan, Ivory Coast: first results from the cancer registry, 1995–1997. Cancer 89: 653–663
Herrero R and Muñoz N (1999) Human Papillomavirus and Cancer. Newton R, Beral V, Weiss RA (eds), Infections and Human Cancer, Cancer Surveys 33, pp. 75–98, Cold Spring Harbor Laboratory Press
IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans, (1994). 59, Hepatitis viruses, The International Agency for Research Cancer: Lyon, France
IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans, (1998). 70, Epstein-Barr Virus and Kaposi's Sarcoma Herpesviris/Human Herpes virus 8, The International Agency for Research Cancer: Lyon, France
Jayant K, Rao RS, Nene BM and Dale PS (1997). Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds), Cancer Incidence in Five Continents, Vol VII, IARC Scientific Publications No.143, International Agency for Research Cancer: Lyon, France
Kew MC (1975) Alpha-fetoprotein. Modern Trends in Gastroenterology, Vol. 5. Read AE (ed). 91 Butterworth: London and Boston
Koulibaly M, Kabba IS, Cisse A, Diallo SB, Diallo MB and Keita N (1997) Cancer incidence in Conakry, Guinea. First Results from the Cancer Registry, 1992–1995. Int J Cancer 70: 39–45
Lennette ET, Blackbourn DJ and Levy JA (1996) Antibodies to human herpes virus type 8 in the general population and Kaposi's sarcoma patients. Lancet 348: 858–861
Meda N, Sangare L, Lankoande S, Sanou PT, Compaore PI, Catraye J, Cartoux M and Soudre RB (1997) Pattern of sexually transmitted diseases among pregnant women in Burkina Faso, West Africa: potential for a clinical management based on simple approaches. Genitourin Med 73: 188–193
Oettlè AG (1962) Geographic and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta UICC 18: 17–54
O'Donovan D, Ariyoshi K, Milligan P, Ota M, Yamuah L, Sarge-Njie R and Whittle H (2000) Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS 14: 441–448
Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH and Whelan SL (1994) Comparability and Quality Control in Cancer Registration, IARC Technical Report No. 19. International Agency for Research Cancer: Lyon, France
Parkin DM, Whelan SL, Ferlay J, Raymond L and Young J (eds) (1997). Cancer Incidence in Five Continents, Vol VII, IARC Scientific Publications No. 143, International Agency for Research Cancer: Lyon, France
Percy C, Van Holten V and Muir C (eds) (1990). International Classification of Diseases for Oncology, World Health Organization: Geneva, Switzerland
Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN and Groopman JD (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shangai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3: 3–10
Rajkumar R, Sankaranarayanan R, Esmi A, Jayaraman R, Cherian J and Parkin DM (2000) Leads to cancer control based on cancer patterns in a rural population in South India. Cancer Causes and Control 11: 433–439
Ryder WR, Whittle HC, Sanneh ABK, Ajdukiewicz AB, Stevenson T and Yvonnet B (1992) Persistent Hepatitis B Virus Infection and Hepatoma in The Gambia, West Africa. Am J Epidemiol 136: 1122–1131
Smith PG (1992) Comparison between registries: age standardized rates. Parkin DM, Whelan SI, Ferlay J, Raymond I, Young J (1997). Cancer Incidence in Five Continents, Vol VII, IARC Scientific Publications No. 143, International Agency for Research Cancer: Lyon, France. pp. 865–870
The Gambia Hepatitis Study Group: Hall AJ, Inskip HM and Loik F (1987) The Gambia Hepatitis Intervention Study. Cancer Res 47: 5782
Tortey E, Coursaget P and Cotty T others (1985) Real time ultrasonography in the detection of primary liver cancer in intertropical Africa. Lancet i: 514
Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R and Whittle HC (1999) Hepatitis B vaccination in infancy in the Gambia: protection against carriage at 9 years of age. Vaccine 17: 2946–2950
Wabinga HR, Parkin DM, Wabwire Mangen F and Nambooze S (2000) Trends in cancer incidence in Kyadondo County, Uganda 1960–1997. Brit J Cancer 82: 1585–1592
Waterhouse JAH, Muir CS, Shanmugaratnam K and Powell J (eds) (1982). Cancer Incidence in Five Continents, Vol IV, IARC Scientific Publications no.42, 210 International Agency for Research on Cancer: Lyon, France
Whittle H, Inskip H and Bradley AK (1990) The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis 161: 1112–1115
Wild CP, Jiang Y-Z, Allen SJ, Jansen LAM, Hall AJ and Montesano R (1990) Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis 11: 2271–2274
Wild CP, Fortuin M, Francesco D, Whittle HC, Hall AJ, Roland W and Montesano R (1993) Aflatoxin, Liver Enzymes, and Hepatitis B Virus Infection in Gambian Children. Cancer Epidemiol Biomarkers and Prev 2: 1–7
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Bah, E., Parkin, D., Hall, A. et al. Cancer in The Gambia: 1988–97. Br J Cancer 84, 1207–1214 (2001). https://doi.org/10.1054/bjoc.2001.1730
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1730
Keywords
This article is cited by
-
Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry
BMC Cancer (2014)
-
Trends in the incidence of primary liver cancer in Central Uganda, 1960–1980 and 1991–2005
British Journal of Cancer (2009)
-
Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care
Cancer Causes & Control (2009)
-
Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia
Virology Journal (2006)
-
249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma
Oncogene (2005)